VTRS Stock Analysis: Buy, Sell, or Hold?
VTRS - Viatris Inc. Common Stock
$15.56
-0.13 (-0.83%)
▼
5d:
-4.48%
30d:
+2.37%
90d:
+5.78%
BUY
HIGH Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Smart Money Accumulation
None View Scanner →
Strength: 9.0/10
Get Alerted When VTRS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: VTRS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: VTRS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$19.67
Based on 6.4% avg growth
INTRINSIC VALUE TODAY
$12.22
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VTRS is currently trading at $15.56, which is considered slightly low relative to its 30-day fair value range of $15.32 to $16.93. The stock's valuation (Forward PE: 5.8) is in line with its historical norms (5.4). At these levels, the market is pricing in 2.4% annual earnings growth.
Technical Outlook: Technically, VTRS is in a strong uptrend. The price is currently testing key support at $15.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.06 (+16.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VTRS is in a strong uptrend. The price is currently testing key support at $15.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.06 (+16.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$15.32 -
$16.93
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($18.06)
- BULLISH: Expecting earnings turnaround to 2.4% growth with 8.1% revenue growth
Trading Range Analysis
30-Day Trading Range
$15.32 -
$16.93
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$15.50
Resistance Level
$16.76
Current Trend
Strong Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.82
Wall Street Target
$18.06
(+16.0%)
Revenue Growth (YoY)
8.1%
Earnings Growth (YoY)
-70.6%
Profit Margin
-2.0%
Valuation Premium vs History
+2.4% premium
PE vs Historical
5.8 vs 5.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.4%
(market-implied from PE analysis)
1-Year Target
$15.93
(+2%)
2-Year Target
$16.32
(+5%)
3-Year Target
$16.71
(+7%)
3-Yr Target (if PE normalizes)
(PE: 6→5)
PE COMPRESSION
$15.50
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 8.8%)
$75.44
(+385%)
Base:
(SPY PE: 5.8, Growth: 8.8%)
$20.04
(+29%)
Bear:
(PE: 4.9, Growth: 8.8%)
$17.04
(+10%)
Share & Embed Analysis
Last updated: June 03, 2026 7:12 PM ET
Data refreshes hourly during market hours. Next update: 8:12 PM
Data refreshes hourly during market hours. Next update: 8:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VTRS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Paul Campbell
SELL
21350 shares
2026-03-23
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$192 | 66 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 60 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$104 | 56 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 55 HOLD |
Advanced VTRS Option Strategies
Professional options setups generated by AI based on today's VTRS price and gamma walls.
